Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Pravibismane

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Microbion Reports Positive Phase 2 Data for Diabetic Foot Ulcers
    Microbion Reports Positive Phase 2 Data for Diabetic Foot Ulcers

    13 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/microbion-announces-positive-topline-results-from-phase-2-study-of-topical-pravibismane-for-moderately-infected-diabetic-foot-ulcers-302303634.html

    PR NEWSWIRE
    13 Nov 2024
    Share Share
    Microbion Pravibismane Ph 1b DFU Published in International Wound Journal
    Microbion Pravibismane Ph 1b DFU Published in International Wound Journal

    04 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/microbions-topical-pravibismane-phase-1b-moderate-or-severe-diabetic-foot-ulcer-infection-study-is-published-in-international-wound-journal-302107893.html

    PR NEWSWIRE
    04 Apr 2024
    Share Share
    Microbion Presented Pravibismane Data Against Mycobacteroides abscessus
    Microbion Presented Pravibismane Data Against Mycobacteroides abscessus

    15 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/microbion-presented-new-pravibismane-data-against-mycobacteroides-abscessus-at-the-6th-world-bronchiectasis-and-ntm-conference-301899119.html

    PR NEWSWIRE
    15 Aug 2023
    Share Share
    Microbion Granted US Patent for Use of Inhaled Pravibismane
    Microbion Granted US Patent for Use of Inhaled Pravibismane

    04 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/microbion-corp-granted-us-patent-for-the-use-of-inhaled-pravibismane-for-pulmonary-infections-301788942.html

    PR NEWSWIRE
    04 Apr 2023
    Share Share
    Microbion Initiates Phase 2 Clinical Study Evaluating Topical Pravibismane
    Microbion Initiates Phase 2 Clinical Study Evaluating Topical Pravibismane

    09 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/microbion-corporation-initiates-phase-2-clinical-study-evaluating-topical-pravibismane-treatment-of-diabetic-foot-infections-301767435.html

    PR NEWSWIRE
    09 Mar 2023
    Share Share
    Microbion Highlights Pravibismane Activity Against Cystic Fibrosis
    Microbion Highlights Pravibismane Activity Against Cystic Fibrosis

    03 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/microbion-corporation-announces-poster-highlighting-pravibismane-activity-against-common-cystic-fibrosis-pulmonary-pathogens-to-be-presented-at-the-north-american-cystic-fibrosis-conference-2022-301667118.html

    PRNEWSWIRE
    03 Nov 2022
    Share Share